Epiphyseal hip correction
This article was originally published in Clinica
Executive Summary
In the profile of British Technology Group published in Clinica No 640 the photograph on page 16 was not the epiphyseal hip as stated. The epiphyseal hip has been developed by Richard Field, a consultant orthopaedic surgeon at St Helier Hospital in Surrey, UK, and Neil Rushton, director of the orthopaedic research unit in Cambridge. It is intended to replace only that part of the femoral head which lies above the epiphyseal scar plate. The prosthesis is constructed using composite materials which closely match the stiffness pattern of the natural bone. Clinical trials on the acetabular component of the epiphyseal hip began in 1994. Clinica regrets any embarrassment caused to Mr Field by the error in the original article.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.